| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
ELANTAS Beck India Ltd
BSE:500123
ELANTAS Beck India Ltd
Cost of Revenue
ELANTAS Beck India Ltd
Cost of Revenue Peer Comparison
NAVINFLUOR
AARTIIND
ASIANPAINT
FLUOROCHEM
VINATIORGA
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
E
|
ELANTAS Beck India Ltd
BSE:500123
|
Cost of Revenue
-₹4.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Cost of Revenue
-₹9.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Aarti Industries Ltd
NSE:AARTIIND
|
Cost of Revenue
-₹38.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Cost of Revenue
-₹200.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Cost of Revenue
-₹22.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Vinati Organics Ltd
NSE:VINATIORGA
|
Cost of Revenue
-₹11B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
See Also
What is ELANTAS Beck India Ltd's Cost of Revenue?
Cost of Revenue
-4.2B
INR
Based on the financial report for Mar 31, 2024, ELANTAS Beck India Ltd's Cost of Revenue amounts to -4.2B INR.
What is ELANTAS Beck India Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%
Over the last year, the Cost of Revenue growth was 2%. The average annual Cost of Revenue growth rates for ELANTAS Beck India Ltd have been -20% over the past three years , -9% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
